Quarterly report pursuant to Section 13 or 15(d)

Schedule of Reclassification of Condensed Consolidated Balance Sheet Information (Details)

v3.21.2
Schedule of Reclassification of Condensed Consolidated Balance Sheet Information (Details) - USD ($)
Jun. 30, 2021
Mar. 31, 2021
Dec. 31, 2020
Jun. 30, 2020
Jun. 02, 2020
Mar. 31, 2020
Jan. 02, 2020
Dec. 31, 2019
Dec. 29, 2019
Multiemployer Plan [Line Items]                  
Cash $ 2,127,372   $ 148,284            
Prepaid expenses 744,561   1,218            
Due from affiliate                
Total Current Assets 22,374,934   149,502            
Operating Lease Right-of-Use 74,872   527,195       $ 1,014,636    
Intangible Assets, net                
Total Non-Current Assets 12,073,411   527,195            
Total Assets 34,448,345   676,697            
Trade and Other Payables 3,298,637   1,801,729            
Due to Related Party                
Interest Payable, related party                
Loan Payable     1,200,000            
Operating Lease Payable 49,522   481,049            
Paycheck Protection Program Loan     70,600            
Total Current Liabilities 3,348,159   3,553,378            
Line of Credit Payable – related party, net of discount   2,333,984            
Interest Payable, related party                
Operating Lease Payable, net of current portion 25,851   46,369   $ 1,016,015        
Total Non-Current Liabilities 25,851   2,380,353            
Total Liabilities 3,374,010   5,933,731            
Commitments and Contingencies              
STOCKHOLDERS’ DEFICIT                  
Common stock, par $0.0001, 100,000,000 shares authorized and 73,991,413 issued and outstanding as of December 31, 2020   4,004            
Additional Paid in Capital   43,411,487            
Accumulated Deficit (69,854,565)   (48,672,525)            
Total Stockholders’ Equity/(Deficit) 31,074,335 $ (8,346,738) (5,257,034) $ (3,051,439)   $ (2,664,780)   $ (2,332,831.00) $ (1,726,363)
Total Liabilities and Stockholders’ Equity/(Deficit) 34,448,345   676,697            
Trade and Other Payables     244,485            
Operating Lease Payable $ 75,373                
Supera Pharmaceuticals Inc [Member]                  
Multiemployer Plan [Line Items]                  
Due from affiliate     24,600            
Operating Lease Right-of-Use     527,195            
Trade and Other Payables     24,600            
Due to Related Party     39,177            
Interest Payable, related party     175,679            
Interest Payable, related party     29,628            
Operating Lease Payable, net of current portion     46,369            
STOCKHOLDERS’ DEFICIT                  
Additional Paid in Capital     1            
Accumulated Deficit     223            
Operating Lease Payable     481,049            
Pro Forma [Member]                  
Multiemployer Plan [Line Items]                  
Cash     133,733            
Prepaid expenses     1,218            
Due from affiliate                
Total Current Assets     134,951            
Operating Lease Right-of-Use                
Intangible Assets, net                
Total Non-Current Assets                
Total Assets     134,951            
Trade and Other Payables     1,025,063            
Due to Related Party     39,177            
Interest Payable, related party     175,679            
Loan Payable     1,200,000            
Operating Lease Payable                
Paycheck Protection Program Loan     54,000            
Total Current Liabilities     2,493,919            
Line of Credit Payable – related party, net of discount     1,734,237            
Interest Payable, related party                
Operating Lease Payable, net of current portion                
Total Non-Current Liabilities     1,734,237            
Total Liabilities     4,228,156            
STOCKHOLDERS’ DEFICIT                  
Common stock, par $0.0001, 100,000,000 shares authorized and 73,991,413 issued and outstanding as of December 31, 2020     4,004            
Additional Paid in Capital     43,411,488            
Accumulated Deficit     (47,508,697)            
Total Stockholders’ Equity/(Deficit)     (4,093,205)            
Total Liabilities and Stockholders’ Equity/(Deficit)     134,951            
Pro Forma [Member] | Supera Pharmaceuticals Inc [Member]                  
Multiemployer Plan [Line Items]                  
Cash     14,551            
Prepaid expenses                
Due from affiliate     24,600            
Total Current Assets     39,151            
Operating Lease Right-of-Use                
Intangible Assets, net                
Total Non-Current Assets                
Total Assets     39,151            
Trade and Other Payables     556,781            
Due to Related Party                
Interest Payable, related party                
Loan Payable                
Operating Lease Payable                
Paycheck Protection Program Loan     16,600            
Total Current Liabilities     573,381            
Line of Credit Payable – related party, net of discount     599,747            
Interest Payable, related party     29,628            
Operating Lease Payable, net of current portion                
Total Non-Current Liabilities     629,375            
Total Liabilities     1,202,756            
STOCKHOLDERS’ DEFICIT                  
Common stock, par $0.0001, 100,000,000 shares authorized and 73,991,413 issued and outstanding as of December 31, 2020                
Additional Paid in Capital                
Accumulated Deficit     (1,163,605)            
Total Stockholders’ Equity/(Deficit)     (1,163,605)            
Total Liabilities and Stockholders’ Equity/(Deficit)     39,151            
Adjustments [Member]                  
Multiemployer Plan [Line Items]                  
Cash                
Prepaid expenses                
Due from affiliate     (24,600)            
Total Current Assets     (24,600)            
Operating Lease Right-of-Use     527,195            
Intangible Assets, net                
Total Non-Current Assets     527,195            
Total Assets     502,595            
Trade and Other Payables     219,885            
Due to Related Party     (39,177)            
Interest Payable, related party     (175,679)            
Loan Payable                
Operating Lease Payable     481,049            
Paycheck Protection Program Loan                
Total Current Liabilities     486,078            
Line of Credit Payable – related party, net of discount                
Interest Payable, related party     (29,628)            
Operating Lease Payable, net of current portion     46,369            
Total Non-Current Liabilities     16,741            
Total Liabilities     502,819            
STOCKHOLDERS’ DEFICIT                  
Common stock, par $0.0001, 100,000,000 shares authorized and 73,991,413 issued and outstanding as of December 31, 2020                
Additional Paid in Capital     (1)            
Accumulated Deficit     (223)            
Total Stockholders’ Equity/(Deficit)     (224)            
Total Liabilities and Stockholders’ Equity/(Deficit)     $ 502,595